Atenci a la mujer con Esclerosis Mtiple en el embarazo, parto y puerperio


Resumen


La esclerosis mtiple (EM) es una enfermedad consistente en la aparici de lesiones desmielinizantes, neurodegenerativas y cricas del sistema nervioso central. Afecta a 1 de cada 1.000 personas en los paes occidentales y con mayor frecuencia a mujeres en edad ftil.

En te artulo revisaremos la evidencia cientica de co el embarazo, puerperio y lactancia materna afecta a la progresi de la enfermedad en la mujer con esclerosis mtiple. Tambi veremos cuales son los factores modificables, como la lactancia materna exclusiva, el dicit de vit D, la evoluci previa de la enfermedad, la dieta, tabaco, alcohol, estr, falta de sue y los tratamientos inmunomoduladores etc. para que la mujer con Esclerosis Mtiple (EM) pueda quedarse embarazada, tener un ni sano y que to le afecte lo menor posible al transcurso de su enfermedad.

La matrona es la profesional que m cerca ta de la mujer durante todos los momentos de su vida, y fundamentalmente en su etapa reproductiva.

Por ese motivo, el objetivo de nuestro estudio, es proporcionarles una informaci con base cientica sobre la enfermedad, su progresi y que factores pueden ser modificables para reducir el nero de recaas despu del parto. Aspodrmejorar su capacidad para atender a las mujeres con esclerosis mtiple en esta oca de su vida y proporcionar unos cuidados de calidad, una informaci clara y eficaz para el cuidado de la salud.


Texto completo:

PDF

Referencias


-Raine CS, McFarland F, Tourtellotte. Esclerosis mltiple.Bases clnicas y patolgicas. Madrid: Edimsa, 2000; 12-8.

-Hellwig K, Haghikia A, Rockhoff M. Multiple sclerosis and pregnancy: experience from a nationwide database in Germany, Ther. Adv. Neurol. Disord. 5 (2012) 247253.

-Finkelsztejn A, Brooks JB, Paschoal FM Jr, et al. What can we really tell women with multiple sclerosis regarding pregnancy? A systematic review and meta-analysis of the literature. BJOG 118(7), (2011)790797.

-Confavreux C, Hutchinson M, Hours MM, et al. Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in Multiple Sclerosis Group. N. Engl. J. Med. 339(5), 285291 (1998).

-Langer-Gould A, Huang SM, Gupta R,et al. Exclusive breastfeeding and the risk of postpartum relapses in women with multiple sclerosis. Arch Neurol. 2009 Aug; 66(8): 958-63.

-Nelson L.M, Franklin G.M, Jones M.C. Risk of multiple sclerosis exacerbation during pregnancy and breast-feeding, JAMA 259 (1988) 34413443.

-Alonso A, Jick SS, Olek MJ,et al. Recentuse of oral contraceptives and the risk of multiple sclerosis. Arch Neurol. 2005;62:1362-1365.

-Portaccio E, Ghezzi A, Hakiki B, et al. Breastfeeding is not related to postpartum relapses in multiple sclerosis, Neurology 77 (2011) 145150.

-Pakpoor J, Disanto G, Lacey MV,et al. Breastfeeding and multiple sclerosis relapses: a meta-analysis. J Neurol. 2012 Oct;259(10):2246-8.

-Salminen HJ, Leggett H, Boggild M. Glatiramer acetate exposure in pregnancy:preliminary safety and birth outcomes. J. Neurol. 257(12), 20202023 (2010).

-Sandberg-Wollheim M, Alteri E, Moraga MS, et al. Pregnancy outcomes in multiple sclerosis following subcutaneous interferon ?-1a therapy. Mult. Scler. 17(4), 423430 (2011).

-Achiron A, Kishner I, Dolev M et al. Effect of intravenous immunoglobulin treatment on pregnancy and postpartum-related relapses in multiple sclerosis. J. Neurol. 251(9), 11331137 (2004).

-Bay Bjorn AM, Ehrenstein V, Holmager Hundborg H, et al. Use of corticosteroids in early pregnancy is not associated with risk of oral clefts and other congenital malformations in offspring. Am. J. Ther. doi:10.1097/MJT.0b013e3182491e02 (2012).

-Elliott AB, Chakravarty EF. Immunosuppressive medications during pregnancy and lactation in women with autoimmune diseases. Womens. Health (Lond. Engl). 6(3), 431440 (2010).

-Hollis B.W, Wagner C.L. Vitamin D requirements during lactation: high-dose maternal supplementation as therapy to prevent hypovitaminosis d for both the mother and the nursing infant, Am. J. Clin. Nutr. 80 (2004) 1752S1758S.

-Charles Pierrot-Deseilligny. Clinical implications of a possible role of vitamin D in multiple sclerosis. Neurol. 2009 September; 256(9): 14681479. Published online 2009 April 28 .

-Jan D, Andrea D Ring, Friedemann Paul. Can we prevent or treat multiple sclerosis by individualised vitamin D supply?.EPMA J.2013,4(1):4. Published online 2013 January 29.

-B.W. Hollis, C.L. Wagner. Assessment of dietary vitamin D requirements during pregnancy and lactation, Am. J. Clin. Nutr. 79 (2004) 717726.

-A.M. Bader, C.O. Hunt, S. Datta, J.S. Et al. Anesthesia for the obstetric patient with multiple sclerosis, J.Clin. Anesth. 1 (1988) 2124.

-B. Runmarker, O. Andersen. Pregnancy is associated with a lower risk of onset and a better prognosis in multiple sclerosis,Brain 118 (Pt 1) (1995) 253261.

-M.B. D'Hooghe, P. Haentjens, G. Nagels, T. D'Hooghe, et al. Oral contraceptives, pregnancy and progression of disability in relapsing onset and progressive onset multiple sclerosis, J. Neurol. 259 (2012) 855861.

-Dhooghe MB, Nagels G, Bissay V, et al. Modifiable factors influencing relapses and disability in multiple sclerosis. Mult. Scler. 16(7), 773785 (2010).

-Past L, Portaccio E, Ghezzi A et al.; MS Study Group of the Italian Neurological Society. Epidural analgesia and cesarean delivery in multiple sclerosis post-partum relapses: the Italian cohort study. BMC Neurol. 12, 165 (2012).

-Hellwig K, Beste C, Brune N , et al. Increase MS relapse rate during assisted reproduction technique.J Neurol 2008;255:592-3.

-Stuart M, Bergstrom L. Prgnancy and multiple sclerosis. The American College of Nurse-Midwives. 56(2011) 41-47.

-Dhooghe MB, Nagels G, Bissay V, et al. Modifiable factors influencing relapses and disability in multiple sclerosis.Mult. Scler. 16(7), 773785 (2010).

-Past L, Portaccio E, Ghezzi A et al.; MS Study Group of the Italian Neurological Society. Epidural analgesia and cesarean delivery in multiple sclerosis post-partum relapses: the Italian cohort study. BMC Neurol. 12, 165 (2012).

-B.W. Hollis, C.L. Wagner, Assessment of dietary vitamin D requirements during pregnancy and lactation, Am. J. Clin. Nutr. 79 (2004) 717726.

-A. Ascherio, K.L. Munger. Environmental risk factors for multiple sclerosis. Part II: noninfectious factors, Ann. Neurol.61 (2007) 504513.

-Vukusic S, Hutchinson M, HoursM, et al; The Pregnancy in Multiple Sclerosis Group.

-Herrera BM, Ramagopalan SV, Orton S, et al. Parental transmission or MS in a population-based Canadian cohort. Neurology 2007;69:1208-12.

-Hoppenbrouwers IA, LiuF, Aulchenko YS, et al. Maternal transmission of multiple sclerosis in a Dutch population. Arch Neurol 2008;65:345-8.


Enlaces refback

  • No hay ningún enlace refback.


Copyright (c) 2014

Licencia Creative Commons
Este trabajo está licenciado bajo una Licencia Internacional Creative Commons 4.0 Atribución-NoComercial-CompartirIgual .

SOPORTE: manuel.jimenez.ruiz.sspa@juntadeandalucia.es